171 related articles for article (PubMed ID: 23420306)
21. HIV infection and zidovudine use in childbearing women.
Sia J; Paul S; Martin RM; Cross H
Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
[TBL] [Abstract][Full Text] [Related]
22. Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects.
Pasternak B; Hviid A
JAMA; 2010 Aug; 304(8):859-66. PubMed ID: 20736469
[TBL] [Abstract][Full Text] [Related]
23. Changing Patterns and Factors Associated With Mode of Delivery Among Pregnant Women With Human Immunodeficiency Virus Infection in the United States.
Venkatesh KK; Morrison L; Livingston EG; Stek A; Read JS; Shapiro DE; Tuomala RE
Obstet Gynecol; 2018 May; 131(5):879-890. PubMed ID: 29630021
[TBL] [Abstract][Full Text] [Related]
24. Safety of oseltamivir in pregnancy: a review of preclinical and clinical data.
Donner B; Niranjan V; Hoffmann G
Drug Saf; 2010 Aug; 33(8):631-42. PubMed ID: 20635821
[TBL] [Abstract][Full Text] [Related]
25. Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.
Floridia M; Mastroiacovo P; Tamburrini E; Tibaldi C; Todros T; Crepaldi A; Sansone M; Fiscon M; Liuzzi G; Guerra B; Vimercati A; Vichi F; Vicini I; Pinnetti C; Marconi AM; Ravizza M;
BJOG; 2013 Nov; 120(12):1466-75. PubMed ID: 23721372
[TBL] [Abstract][Full Text] [Related]
26. Perinatal outcomes following maternal pre-exposure prophylaxis (PrEP) use during pregnancy: results from a large PrEP implementation program in Kenya.
Dettinger JC; Kinuthia J; Pintye J; Abuna F; Begnel E; Mugwanya K; Sila J; Lagat H; Baeten JM; John-Stewart G
J Int AIDS Soc; 2019 Sep; 22(9):e25378. PubMed ID: 31498563
[TBL] [Abstract][Full Text] [Related]
27. Reconsidering the Number of Women With HIV Infection Who Give Birth Annually in the United States.
Nesheim SR; FitzHarris LF; Lampe MA; Gray KM
Public Health Rep; 2018 Nov; 133(6):637-643. PubMed ID: 30265616
[TBL] [Abstract][Full Text] [Related]
28. The safety of oseltamivir in pregnancy: an updated review of post-marketing data.
Wollenhaupt M; Chandrasekaran A; Tomianovic D
Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1035-42. PubMed ID: 24995623
[TBL] [Abstract][Full Text] [Related]
29. Pregnancy outcomes of women exposed to laninamivir during pregnancy.
Minakami H; Kubo T; Nakai A; Saito S; Unno N
Pharmacoepidemiol Drug Saf; 2014 Oct; 23(10):1084-7. PubMed ID: 25074683
[TBL] [Abstract][Full Text] [Related]
30. Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant.
Yates L; Pierce M; Stephens S; Mill AC; Spark P; Kurinczuk JJ; Valappil M; Brocklehurst P; Thomas SH; Knight M
Health Technol Assess; 2010 Jul; 14(34):109-82. PubMed ID: 20630123
[TBL] [Abstract][Full Text] [Related]
31. Smallpox vaccination and adverse reactions. Guidance for clinicians.
Cono J; Casey CG; Bell DM;
MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
[TBL] [Abstract][Full Text] [Related]
32. In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States.
Griner R; Williams PL; Read JS; Seage GR; Crain M; Yogev R; Hazra R; Rich K;
AIDS Patient Care STDS; 2011 Jul; 25(7):385-94. PubMed ID: 21992592
[TBL] [Abstract][Full Text] [Related]
33. Clinical course and perinatal transmission of chronic hepatitis B during pregnancy: A real-world prospective cohort study.
Chen ZX; Gu GF; Bian ZL; Cai WH; Shen Y; Hao YL; Zhang S; Shao JG; Qin G
J Infect; 2017 Aug; 75(2):146-154. PubMed ID: 28551372
[TBL] [Abstract][Full Text] [Related]
34. Update on Neonatal Herpes Simplex Epidemiology in the Netherlands: A Health Problem of Increasing Concern?
van Oeffelen L; Biekram M; Poeran J; Hukkelhoven C; Galjaard S; van der Meijden W; Op de Coul E
Pediatr Infect Dis J; 2018 Aug; 37(8):806-813. PubMed ID: 29356762
[TBL] [Abstract][Full Text] [Related]
35. SARS-COV-2 infection in pregnant women and newborns in a Spanish cohort (GESNEO-COVID) during the first wave.
Carrasco I; Muñoz-Chapuli M; Vigil-Vázquez S; Aguilera-Alonso D; Hernández C; Sánchez-Sánchez C; Oliver C; Riaza M; Pareja M; Sanz O; Pérez-Seoane B; López J; Márquez E; Domínguez-Rodríguez S; Hernanz-Lobo A; De León-Luis JA; Sánchez-Luna M; Navarro ML
BMC Pregnancy Childbirth; 2021 Apr; 21(1):326. PubMed ID: 33902483
[TBL] [Abstract][Full Text] [Related]
36. Adolescent and young pregnant women at increased risk of mother-to-child transmission of HIV and poorer maternal and infant health outcomes: A cohort study at public facilities in the Nelson Mandela Bay Metropolitan district, Eastern Cape, South Africa.
Fatti G; Shaikh N; Eley B; Jackson D; Grimwood A
S Afr Med J; 2014 Dec; 104(12):874-80. PubMed ID: 26042271
[TBL] [Abstract][Full Text] [Related]
37. Update on viral hepatitis in pregnancy.
Shao Z; Al Tibi M; Wakim-Fleming J
Cleve Clin J Med; 2017 Mar; 84(3):202-206. PubMed ID: 28322675
[TBL] [Abstract][Full Text] [Related]
38. Treatment and prevention of viral hepatitis in pregnancy.
Dionne-Odom J; Cozzi GD; Franco RA; Njei B; Tita ATN
Am J Obstet Gynecol; 2022 Mar; 226(3):335-346. PubMed ID: 34516961
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection.
Celen MK; Mert D; Ay M; Dal T; Kaya S; Yildirim N; Gulsun S; Barcin T; Kalkanli S; Dal MS; Ayaz C
World J Gastroenterol; 2013 Dec; 19(48):9377-82. PubMed ID: 24409065
[TBL] [Abstract][Full Text] [Related]
40. [Maternal-fetal outcomes of lamivudine treatment administered during late pregnancy to highly viremic mothers with HBeAg+ chronic hepatitis B].
Jiang HX; Han GR; Wang CM; Ji Y
Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):888-91. PubMed ID: 23522247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
